TFA Therapeutics, Inc. (RAJAF) Form 10-Q Quarterly Reports
TFA Therapeutics, Inc. (RAJAF) is a publicly traded company on the OTC, categorized under SIC 2833 (Medicinal Chemicals & Botanical Products). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RAJAF
CIK: 1885680
Exchange: OTC
SIC 2833: Medicinal Chemicals & Botanical Products
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
YCM CPA INC.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerMatthew Schwartz
Audit LocationIrvine, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-09-02 | 2026-09-02 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-096447 | View SEC Doc Filr Page |
| 6-K | 2026-07-27 | 2026-07-27 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-081806 | View SEC Doc Filr Page |
| 6-K | 2026-06-25 | 2026-06-25 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-071711 | View SEC Doc Filr Page |
| 20-F | 2026-05-15 | 2025-12-31 | ANNUAL REPORT | 0001213900-26-057774 | View SEC Doc Filr Page |
| NT 20-F | 2026-04-30 | 2025-12-31 | NOTIFICATION OF LATE FILING | 0001213900-26-050286 | View SEC Doc Filr Page |
| 6-K | 2025-11-26 | 2025-11-25 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-115017 | View SEC Doc Filr Page |
| 20-F/A | 2025-09-23 | 2023-12-31 | AMENDMENT NO. 2 TO FORM 20-F | 0001213900-25-090714 | View SEC Doc Filr Page |
| 20-F | 2025-06-13 | 2024-12-31 | ANNUAL REPORT | 0001213900-25-054317 | View SEC Doc Filr Page |
| NT 20-F | 2025-04-30 | 2024-12-31 | NOTIFICATION OF LATE FILING | 0001213900-25-037684 | View SEC Doc Filr Page |
| 6-K | 2024-12-06 | 2024-12-06 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-24-106507 | View SEC Doc Filr Page |
| UPLOAD | 2024-11-08 | — | UPLOAD Filing | 0000000000-24-012443 | View SEC Doc Filr Page |
| CORRESP | 2024-10-28 | — | CORRESP Filing | 0001213900-24-091130 | View SEC Doc Filr Page |
| 20-F/A | 2024-10-28 | 2023-12-31 | AMENDMENT NO. 1 TO FORM 20-F | 0001213900-24-091107 | View SEC Doc Filr Page |
| UPLOAD | 2024-09-04 | — | UPLOAD Filing | 0000000000-24-010003 | View SEC Doc Filr Page |
| 20-F | 2024-07-05 | 2023-12-31 | ANNUAL REPORT | 0001213900-24-059406 | View SEC Doc Filr Page |
| NT 20-F | 2024-04-30 | 2023-12-31 | NOTIFICATION OF LATE FILING | 0001213900-24-037680 | View SEC Doc Filr Page |
| 6-K | 2024-03-19 | 2024-03-18 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-24-024032 | View SEC Doc Filr Page |
| 6-K | 2023-11-13 | 2023-09-30 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-23-085555 | View SEC Doc Filr Page |
| 6-K | 2023-09-28 | 2023-09-28 | CURRENT REPORT | 0001213900-23-080207 | View SEC Doc Filr Page |
| 20-F | 2023-05-15 | 2022-12-31 | ANNUAL REPORT | 0001213900-23-039368 | View SEC Doc Filr Page |
| NT 20-F | 2023-04-28 | 2022-12-31 | EXTENSION FORM | 0001213900-23-033693 | View SEC Doc Filr Page |
| 424B4 | 2023-03-30 | — | PROSPECTUS | 0001213900-23-024460 | View SEC Doc Filr Page |
| EFFECT | 2023-03-29 | — | EFFECT Filing | 9999999995-23-000709 | View SEC Doc Filr Page |
| CORRESP | 2023-03-27 | — | CORRESP Filing | 0001213900-23-023145 | View SEC Doc Filr Page |
| CORRESP | 2023-03-20 | — | CORRESP Filing | 0001213900-23-021440 | View SEC Doc Filr Page |